Investigational Site Number 840001

Kansas City, Kansas 66160-7321

0 studies enrolling now · 3 studies all time

What they study most

Acid Maltase Deficiency, Glycogen Storage Disease Type II (GSD II), Glycogen Storage Disease Type II Pompe Disease, Hematopoietic Neoplasm, Pompe Disease

Studies at this site

• Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib — Stopped early
• Avalglucosidase Alfa Extension Study — Completed
• Safety and Efficacy Evaluation of Repeat neoGAA Dosing in Late Onset Pompe Disease Patients. — Completed